FDA has weighed in on the latest weight-loss drug lorcaserin hydrochloride (Belviq), approving the Arena Pharmaceutical drug for use in adults with a body mass index (BMI) of 30 or greater and those with a BMI more than 27 and hypertension, type 2 diabetes or dyslipidemia.

An automated lung nodule matching program can improve radiologists efficiency almost two-fold, according to a study published in the July issue of American Journal of Roentgenology.

A new approach to the management of a devastating form of pancreatic cancer could offer hope to patients who were previously told their tumors were inoperable. Using a combination of radiographic restaging, multimodality treatment and advanced surgical techniques, the majority of patients in a recently published study who would have received only palliative, noncurative therapy were deemed to have resectable tumors and saw survival benefits following treatment, according to results appearing in the July issue of the Journal of the American College of Surgeons.

The Certification Commission for Health IT (CCHIT) focused its comments this week on the request for information (RFI) on governance and security of the Nationwide Health Information Network (NwHIN), published in the Federal Register by the Office of the National Coordinator for Health IT (ONC) on May 15.

Screening mammography rates among women in their 40s have dropped nearly 6 percent in the U.S. since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, according to an analysis presented Academy Health Annual Research Meeting, June 24-26, in Orlando, Fla.

Siemens Healthcare has launched the Acuson P300 ultrasound system, a compact portable device designed for various clinical disciplines, including radiology and general imaging, cardiovascular imaging, obstetrics and gynecology and specialty imaging.

Beckman Coulter, the Orange County, Calif.-based biomedical diagnostics products company, has received premarket approval from the FDA for its Prostate Health Index blood test. The phi test is indicated for use in men with a PSA in the range of 4 to 10 ng/mL, who are normally recommended for biopsy by a physician. A multi-center clinical study showed a 31 percent reduction in unnecessary biopsies when utilizing the phi test, according to Beckman Coulter.

The Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy bill (CARE) has been introduced in the U.S. Senate by Sen. Mike Enzi, (R-Wyo.), and Sen. Tom Harkin, (D-Iowa).